Spero Therapeutics Free Cash Flow (Quarterly) Trends

Spero Therapeutics Inc (SPRO)

1.175 -0.08 (-6.00%) USD | NASDAQ | Nov 15, 16:00

1.175 0.00 (0.00%) After-Hours: 16:22

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	-18.74M
March 31, 2024	5.938M
December 31, 2023	-17.49M
September 30, 2023	15.92M
June 30, 2023	-18.56M
March 31, 2023	-12.85M
December 31, 2022	44.48M
September 30, 2022	-0.957M
June 30, 2022	-23.03M
March 31, 2022	-28.22M
December 31, 2021	-27.35M
September 30, 2021	-4.952M
June 30, 2021	-16.57M
March 31, 2021	-15.48M
December 31, 2020	-16.40M

Date	Value
September 30, 2020	-21.32M
June 30, 2020	-24.91M
March 31, 2020	-23.41M
December 31, 2019	-17.50M
September 30, 2019	-9.676M
June 30, 2019	-12.16M
March 31, 2019	-11.00M
December 31, 2018	-15.92M
September 30, 2018	-5.536M
June 30, 2018	-8.641M
March 31, 2018	-11.96M
December 31, 2017	-12.74M
September 30, 2017	-10.52M
June 30, 2017	-8.877M
March 31, 2017	-6.979M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-28.22M

Minimum

Mar 2022

44.48M

Maximum

Dec 2022

-11.65M

Average

-17.49M

Median

Dec 2023

Free Cash Flow (Quarterly) Benchmarks